SCHEMBL6618552

SCHEMBL6618552

CCC1=C2[C@H](CCN2C(=O)OCc2ccccc2)NC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HTR2C P28335 1/20 0.44
MAPK1 P28482 2/20 0.43
GAA P10253 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 1/20 0.40
CCR5 P51681 2/20 0.40
CTSK P43235 2/20 0.39
CTSB P07858 1/20 0.39
CTSS P25774 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7406324 0.86 NPC1 (0.46) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL6619041 0.86 ELANE (0.43) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL6621891 0.86 ELANE (0.43) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL6624131 0.85 NPC1 (0.45) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL6617554 0.83 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL6618031 0.83 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL7989218 0.83 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL6619994 0.83 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL6620544 0.83 NPC1 (0.45) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C
SCHEMBL8132883 0.78 PLA2G2A (0.37) NPC1RAB9ASMN1; SMN2L3MBTL1HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891362-B1 PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE GLAXO GROUP LTD (GB) 2004-03-17 EP disclosed
US-6215002-B1 CYCLIZATION, DEBLOCKING, DEPROTECTION, SULFONATION, CONDENSATION, AMIDATION; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS GLAXO WELLCOME INC. 2001-04-10 US disclosed
US-5994344-A BRONCHITIS THERAPY GLAXO WELLCOME INC. (US) 1999-11-30 US disclosed